Advanced Modalities
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
SynOligo Biotechnologies is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:China
Founded:2018
Employees:1,987
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Global
Regulatory Approvals
Drug Approval ELG1KV
Health Canada · #APR-MDP5CFVV · 2022-06-01
Drug Approval BQJXWC
FDA · #APR-B1FEXYXA · 2020-02-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-7F6Q3HXJ
Issued: 2020-07-02
Expires: 2025-03-14
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-UPXPD35M
Issued: 2020-04-20
Expires: 2025-07-11
Loading CDMO intelligence...
Key facts about SynOligo Biotechnologies
- SynOligo Biotechnologies is headquartered in China.
- SynOligo Biotechnologies was founded in 2018.
- SynOligo Biotechnologies has 1,987 employees.
- SynOligo Biotechnologies's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like SynOligo Biotechnologies
Directory pages this company appears in, each with the full list of matching manufacturers.